Tend Health Inc. – Clinical Study for Tend’s Gut Microbiome Collection and Prep (CAP) Device in Clostridium difficile Infection
Thomas Lendvay, CMO and co-founder of Tend Health, Inc. discusses the recent announcement of the initiation of a clinical trial at Massachusetts General Hospital evaluating the comparability of the company’s Gut Microbiome CAP device to current non-standardized methodologies for the delivery of Fecal Microbiota Transplant (FMT) for patients suffering from Clostridium difficile infection.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Surgery. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Surgery and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Surgery?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Thomas Lendvay, CMO and co-founder of Tend Health, Inc.
- Key Point: discusses the recent announcement of the initiation of a clinical trial at Massachusetts General Hospital evaluating the comparability of the company’s Gut Microbiome CAP device…
- Key Point: He is currently on leave from his position as a Professor in the Department of Urology at the University of Washington and co-Director of Seattle Children’s Robotic Surgery Ce…
- Key Point: Lendvay was the co-founder and Chief Medical Officer of CSATS (acquired by Johnson & Johnson in 2018).
- Key Point: His research and innovation focus on disruptive technologies to improve patient outcomes.
Dr. Lendvay is a surgeon and entrepreneur. He is currently on leave from his position as a Professor in the Department of Urology at the University of Washington and co-Director of Seattle Children’s Robotic Surgery Center, as he focuses on Tend. Dr. Lendvay was the co-founder and Chief Medical Officer of CSATS (acquired by Johnson & Johnson in 2018). His research and innovation focus on disruptive technologies to improve patient outcomes.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



